Maria Inmaculada
Heras Fernando
Asociado Ciencias de la Salud
Joan
Bargay Lleonart
Publications by the researcher in collaboration with Joan Bargay Lleonart (7)
2020
-
Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain
Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 8, pp. 1534-1542
-
UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy
Leukemia, Vol. 34, Núm. 11, pp. 2925-2933
2015
-
Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AML
American Journal of Clinical Pathology, Vol. 144, Núm. 3, pp. 484-492
-
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia
Blood Cancer Journal, Vol. 5, pp. e352
-
The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature
Oncotarget, Vol. 6, Núm. 31, pp. 31613-31627
2013
-
Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML
Leukemia, Vol. 27, Núm. 11, pp. 2157-2164